Clinical Trials Directory

Trials / Completed

CompletedNCT03545841

HIT in People With Type 1 Diabetes

High-Intensity Interval Training Improves Aerobic Capacity and Abolishes the Decline in Blood Glucose Observed During Moderate-Intensity Continuous Training Sessions in People With Type 1 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Liverpool John Moores University · Academic / Other
Sex
Age
Healthy volunteers
Not accepted

Summary

Few people with type 1 diabetes achieve exercise guidelines and many programmes designed to increase physical activity have failed. High-intensity interval training (HIT) has been shown to be a time-efficient alternative to traditional moderate-intensity continuous training (MICT) in various groups without type 1 diabetes. A single bout of HIT does not increase the risk of hypoglycaemia in people with type 1 diabetes. This study aimed to assess whether HIT a safe, effective and time-efficient training strategy to improve cardio-metabolic health and reduce the risk of hypoglycaemia in people with type 1 diabetes.

Detailed description

This study aimed to investigate whether 1) six weeks of high-intensity interval training (HIT) induces similar improvements in cardio-metabolic health markers as moderate-intensity continuous training (MICT) in people with type 1 diabetes, and 2) whether HIT abolishes acute reductions in plasma glucose observed following MICT sessions. Fourteen sedentary individuals with type 1 diabetes (n=7 per group) completed six weeks of HIT or MICT 3 times per week. Pre- and post-training measurements were made of 24h interstitial glucose profiles (using continuous glucose monitors (CGMS)) and cardio-metabolic health markers (V ̇O2peak, blood lipid profile and aortic pulse wave velocity; aPWV). Capillary blood glucose concentrations were assessed before and after exercise sessions throughout the training programme to investigate changes in blood glucose during exercise in the fed state.

Conditions

Interventions

TypeNameDescription
OTHERHITParticipants completed 6 weeks of HIT
OTHERMICTParticipants completed 6 weeks of MICT

Timeline

Start date
2015-03-09
Primary completion
2017-10-10
Completion
2017-10-10
First posted
2018-06-04
Last updated
2018-06-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03545841. Inclusion in this directory is not an endorsement.

HIT in People With Type 1 Diabetes (NCT03545841) · Clinical Trials Directory